Novo Nordisk has secured approval from the U.S. Food and Drug Administration (FDA) to market its oral GLP-1 medication, Rybelsus, specifically aimed at reducing the risk...
MannKind Corporation has announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental marketing application for Afrezza, an inhalation powder of human insulin....
FluidAI Medical has achieved a significant milestone by obtaining clearance from the United States Food and Drug Administration (FDA) for its innovative device designed to predict...
Shares of Biohaven Pharmaceutical Holding Company Ltd. surged on Wednesday morning after Citi initiated coverage with a Buy rating, setting a price target of $28 per...
The U.S. Food and Drug Administration (FDA) announced on October 23, 2023, its recommendation to lift the voluntary hold on the gene therapy treatment, Elevidys, developed...
GlaxoSmithKline (GSK) announced on Wednesday that the U.S. Food and Drug Administration (FDA) has extended the review period for its blood cancer therapy, Blenrep. This development...
The World Health Organization (WHO) has officially recommended Gilead Sciences’ newly approved HIV pre-exposure prophylaxis (PrEP) medication, Yeztugo (lenacapavir). This endorsement follows its approval by the...
American Diversified Holdings Corporation (ADHC) has announced significant advancements in the development of its innovative GlucoGuard system, following a detailed update from its partner, Arete Biosciences,...
